Key players in the North American Ophthalmology Surgery Devices Market are Alcon, Abbott Laboratories, BAUSCH & LOMB, Inc., Valeant Pharmaceuticals International, Inc. & others.
(PRWEB) September 23, 2014
The ophthalmology surgery devices market report defines and segments the concerned market in North America with analysis and forecast of revenue. The market was valued $1,849.5 million in 2012 and is estimated to grow at a CAGR of 4.4% from 2013 to 2018.
Browse through the TOC of the North American Ophthalmology surgery devices market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of the market in the same region, and is supported by various tables and figures.
North American region (U.S., Canada, and Mexico) has the largest market for ophthalmology surgery devices. The U.S. has been the prime market for the device companies, due to the favorable reimbursement policies and easy access to the local companies. The market is huge in North America because of the rapidly aging population. Within North America, the U.S. is the biggest market for intraocular lens sharing around 92% in 2012, and it is expected to maintain its share by adopting premium intraocular lens (IOLs), direct-to-consumer (DTC) marketing, and advanced technologies. IOLs are used after the cataract surgery and are adopted in advanced surgeries, such as micro-incision cataract surgery. The increase in the number of ophthalmic ambulatory surgical centers (ASC) has also helped the U.S. to maintain its largest share in the North American ophthalmology surgery market.
Speak to Analyst @
In the North American ophthalmology surgery devices market, the cataract and refractive surgery devices markets have been the major contributing segments, with approximately 80% and 9% share respectively in 2014. Both the markets have been witnessing significant growth because of the increase in patient pool with rise in aging population and age-related diseases.
Incidences of glaucoma and cataract are increasing every year. Cataract is responsible for 48% of the population becoming totally blind, globally. The increasing aging population is also resulting in more people suffering from refractive errors. According to the World Health Organization (WHO), an estimated 20 million cataract surgeries were performed in 2010 globallly; this number is expected to reach 32 million by 2020. This number has increased by 3% for U.S. in 2011 and by same percentage in 2012, thus, driving the ophthalmology surgery devices market in North America.
Early buyers will receive 10% customization on this report.
The major companies extensively covered in this report are Alcon-Novartis (Switzerland) that possesses a lion’s share in the market, followed by Abbott Medical Optics Inc., (U.S.), Bausch & Lomb (U.S.), Allergan, Inc. (U.S.), and others.
The report on the North American ophthalmology surgery devices market analyzes the devices under four segments of cataract, glaucoma, refractive, and vitreoretinal surgery. The cataract surgery device market is further segmented with a deep dive analysis into intraocular lens (IOL), ophthalmic viscoelastic devices (OVD), phacoemulsification devices, and others. Glaucoma devices are segmented into glaucoma drainage devices (GDD), stents and implants, glaucoma lasers, and glaucoma systems. Refractive surgery devices are further categorized as refractive treatment devices and refractive flap-making devices while the vitreoretinal surgery devices are segmented as illumination device, photocoagulation laser, and vitrectomy machines.
The market is further segmented and forecast on the basis of major countries, such as the U.S., Canada, and Mexico. The market is also segmented and analyzed further on the basis of the end-users of the devices covering the hospitals, private eye clinics, and other end-users.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities. In addition, it presents a competitive landscape and company profiles of the key players in the market.
European Ophthalmology Surgery Devices Market
Opthalmology Surgery Devices-Europe market has been pegged at 1,374.1 m in the year 2013 growing at 4.4% annually and is projected to reach 1,703.8 m by the end of the year 2018. Opthalmology Surgery Devices-Europe constitute 26.1% of Global Ophthalmology Surgery Devices market and are poised to grow its market share to 23.1% by the end of year 2018.Peers of Hydrocolloids are Cataract Surgery Devices, Refractive Surgery Devices, Vitreoretinal Surgery Devices and Glaucoma Surgery Devices comprising 79.6%, 9.0%, 8.7% and 2.8% respectively of the Global Ophthalmology Surgery Devices market.It is segmented on basis of endusers and geographies.
Asian Ophthalmology Surgery Devices Market
Opthalmology Surgery Devices-Asia market has been pegged at 1,221.5 m in the year 2013 growing at 11.6% annually and is projected to reach 2,110.9 m by the end of the year 2018. Opthalmology Surgery Devices-Asia constitute 23.2% of Global Ophthalmology Surgery Devices market and are poised to grow its market share to 28.6% by the end of year 2018.Peers of Hydrocolloids are Cataract Surgery Devices, Refractive Surgery Devices, Vitreoretinal Surgery Devices and Glaucoma Surgery Devices comprising 79.6%, 9.0%, 8.7% and 2.8% respectively of the Global Ophthalmology Surgery Devices market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.